BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21774295)

  • 1. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
    Aydemir H; Celebi G; Piskin N; Oztoprak N; Keskin AS; Aktas E; Sumbuloglu V; Akduman D
    Jpn J Infect Dis; 2012; 65(1):66-71. PubMed ID: 22274161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
    Jamulitrat S; Arunpan P; Phainuphong P
    J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    Rodríguez Guardado A; Blanco A; Asensi V; Pérez F; Rial JC; Pintado V; Bustillo E; Lantero M; Tenza E; Alvarez M; Maradona JA; Cartón JA
    J Antimicrob Chemother; 2008 Apr; 61(4):908-13. PubMed ID: 18281693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
    Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
    Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital.
    Phumisantiphong U; Diraphat P; Utrarachkij F; Uaratanawong S; Siripanichgon K
    J Med Assoc Thai; 2009 Dec; 92 Suppl 7():S173-80. PubMed ID: 20232570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.
    Shields RK; Kwak EJ; Potoski BA; Doi Y; Adams-Haduch JM; Silviera FP; Toyoda Y; Pilewski JM; Crespo M; Pasculle AW; Clancy CJ; Nguyen MH
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
    Anunnatsiri S; Tonsawan P
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London.
    Livermore DM; Hill RL; Thomson H; Charlett A; Turton JF; Pike R; Patel BC; Manuel R; Gillespie S; Balakrishnan I; Barrett SP; Cumberland N; Twagira M;
    Int J Antimicrob Agents; 2010 Jan; 35(1):19-24. PubMed ID: 19910162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for Acinetobacter baumannii infections.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
    Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
    Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
    J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.